Randomized Trial to Prevent Vascular Events in HIV - REPRIEVE
Phase of Trial: Phase IV
Latest Information Update: 17 Feb 2018
At a glance
- Drugs Pitavastatin (Primary)
- Indications Cardiovascular disorders
- Focus Therapeutic Use
- Acronyms REPRIEVE
- 14 Jun 2017 Trial phase has been changed from Phase 3 to Phase 4.
- 10 Jun 2017 Biomarkers information updated
- 23 Mar 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.